Pu‐Yun OuYang

1.5k total citations
48 papers, 1.1k citations indexed

About

Pu‐Yun OuYang is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Pu‐Yun OuYang has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Otorhinolaryngology, 25 papers in Surgery and 22 papers in Oncology. Recurrent topics in Pu‐Yun OuYang's work include Head and Neck Cancer Studies (34 papers), Head and Neck Surgical Oncology (16 papers) and Lung Cancer Research Studies (9 papers). Pu‐Yun OuYang is often cited by papers focused on Head and Neck Cancer Studies (34 papers), Head and Neck Surgical Oncology (16 papers) and Lung Cancer Research Studies (9 papers). Pu‐Yun OuYang collaborates with scholars based in China and United States. Pu‐Yun OuYang's co-authors include Fang‐Yun Xie, Zhen Su, Mingyang Sun, Alton B. Kremer, Zuo‐Feng Zhang, Ivan D. Horak, Howard I. Scher, Yan‐Ping Mao, Chuan Xie and Qinqin Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Pu‐Yun OuYang

47 papers receiving 1.1k citations

Peers

Countries citing papers authored by Pu‐Yun OuYang

Since Specialization

Citations

This map shows the geographic impact of Pu‐Yun OuYang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pu‐Yun OuYang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pu‐Yun OuYang more than expected).

Fields of papers citing papers by Pu‐Yun OuYang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pu‐Yun OuYang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pu‐Yun OuYang. The network helps show where Pu‐Yun OuYang may publish in the future.

Co-authorship network of co-authors of Pu‐Yun OuYang

This figure shows the co-authorship network connecting the top 25 collaborators of Pu‐Yun OuYang. A scholar is included among the top collaborators of Pu‐Yun OuYang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pu‐Yun OuYang. Pu‐Yun OuYang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway 2023 ·Journal of Translational Medicine ·(unknown), Jiajia Huang, Miao Chen, (unknown), Pu‐Yun OuYang, Xiaonan Wang, Dingbo Shi, (unknown), (unknown), (unknown), Shanshan Yang, (unknown), Wuguo Deng, Huijuan Qiu, Fang‐Yun Xie	10
2	Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma 2023 ·Oral Oncology ·(unknown), Yanan Zhao, Yi‐Shan Wu, (unknown), (unknown), (unknown), (unknown), Dian Ouyang, Fang‐Yun Xie, Pu‐Yun OuYang	11
3	Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort study 2023 ·EClinicalMedicine ·Pu‐Yun OuYang, Yun He, (unknown), Jiani Liu, Zhilong Wang, (unknown), Jiajian Li, Shanshan Yang, Xu Zhang, Wei Fan, Yi‐Shan Wu, (unknown), (unknown), Yanan Zhao, Mingyong Gao, Weijun Zhang, Chuanmiao Xie, Fang‐Yun Xie	9
4	Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Shanshan Yang, Pu‐Yun OuYang, (unknown), Jiajun Cai, Jun Zhang, (unknown), Yun He, (unknown), (unknown), Xuefeng Hu, Yanfeng Chen, Chunyan Chen, Fang‐Yun Xie	12
5	Role of postoperative chemoradiotherapy in head and neck cancer without positive margins or extracapsular extension: a propensity score-matching analysis 2022 ·Radiation Oncology ·(unknown), Pu‐Yun OuYang, (unknown), (unknown), (unknown), Shanshan Yang, Zhongyuan Yang, Fang‐Yun Xie	3
6	Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Shanshan Yang, Yi‐Shan Wu, Weichao Chen, Jun Zhang, (unknown), (unknown), (unknown), (unknown), Xu Zhang, Pu‐Yun OuYang, Fang‐Yun Xie	16
7	Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis 2021 ·Annals of Translational Medicine ·(unknown), Jiawei Wu, (unknown), Shanshan Yang, Jiali Wu, Pu‐Yun OuYang, Fang‐Yun Xie	2
8	Effect of Induction Chemotherapy in Nasopharyngeal Carcinoma: An Updated Meta-Analysis 2021 ·Frontiers in Oncology ·Shanshan Yang, (unknown), Jiani Liu, (unknown), (unknown), Chunyan Chen, Pu‐Yun OuYang, Fei Han, Fang‐Yun Xie	10
9	Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer 2019 ·Journal of Cancer ·Zhen Su, Guorong Zou, Yan‐Ping Mao, Pu‐Yun OuYang, Xiaolong Cao, Fang‐Yun Xie, Qun Li	10
10	Validation of published nomograms and accordingly individualized induction chemotherapy in nasopharyngeal carcinoma 2017 ·Oral Oncology ·Pu‐Yun OuYang, (unknown), Yao Xiao, (unknown), Xiaomin Zhang, Jun Ma, Fang-Yun Xie	13
11	Validation and comparison of the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi 2017 ·Oral Oncology ·Pu‐Yun OuYang, Yao Xiao, Kaiyun You, Luning Zhang, (unknown), Xiaomin Zhang, Fang‐Yun Xie	26
12	Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma 2016 ·PLoS ONE ·(unknown), (unknown), Yao Xiao, (unknown), Pu‐Yun OuYang, Zhen Su, Fang‐Yun Xie	8
13	The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis 2015 ·British Journal of Cancer ·Pu‐Yun OuYang, (unknown), (unknown), Chuan Xie, (unknown), (unknown), Zhen Su, Jinghua Tang, (unknown)	50
14	Effect of taxanes-based induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A large scale propensity-matched study 2015 ·Oral Oncology ·Luning Zhang, Yuanhong Gao, (unknown), (unknown), Pu‐Yun OuYang, Fang‐Yun Xie	19
15	Friend Leukemia Virus Integration 1 Expression Has Prognostic Significance in Nasopharyngeal Carcinoma 2014 ·Translational Oncology ·(unknown), Dingbo Shi, Jing‐Ping Yun, Yan‐Ping Mao, Pu‐Yun OuYang, Zhen Su, Jia Fu, Jinghui Hou, Wuguo Deng, Fang‐Yun Xie	11
16	Prognostic Impact of Cigarette Smoking on the Survival of Patients with Established Nasopharyngeal Carcinoma 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Pu‐Yun OuYang, Zhen Su, Yan‐Ping Mao, (unknown), Qing Liu, Wuguo Deng, Fang‐Yun Xie	28
17	Prognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinoma 2013 ·British Journal of Cancer ·Pu‐Yun OuYang, Zhen Su, (unknown), (unknown), Qiang Liu, (unknown)	31
18	Prognostic value of ABO blood group in southern Chinese patients with established nasopharyngeal carcinoma 2013 ·British Journal of Cancer ·Pu‐Yun OuYang, Zhi‐Hui Su, (unknown), Qinqin Liu, (unknown)	25
19	Combination of EGFR-TKIs and Chemotherapy as First-Line Therapy for Advanced NSCLC: A Meta-Analysis 2013 ·PLoS ONE ·Pu‐Yun OuYang, Zhen Su, Yan‐Ping Mao, Wuguo Deng, Fang‐Yun Xie	14
20	Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer 1999 ·JNCI Journal of the National Cancer Institute ·Howard I. Scher, W.M. Kelly, Zuo‐Feng Zhang, Pu‐Yun OuYang, Mingyang Sun, (unknown), (unknown), Weizhuo Wang, Ivan D. Horak, Alton B. Kremer	140

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact